Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized

Introduction: Sodium-glucose cotransporter-2 inhibitors (SGLT-2Is) reduce heart failure (HF) hospitalizations and major adverse cardiovascular events (MACE) in general type 2 diabetes populations. The objective of this study was to determine whether SGLT-2Is vs. dipeptidyl peptidase-4 inhibitors (DP...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Stephen J, Bell, J Simon, Magliano, Dianna J, Shaw, Jonathan E, Cesari, Matteo, Ilomaki, Jenni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315378/
https://www.ncbi.nlm.nih.gov/pubmed/35903329
http://dx.doi.org/10.3389/fphar.2022.886834